Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?

Código QR

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?

Guardado en:

Detalles Bibliográficos
Autor principal:	Gianluigi Savarese
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/f61a8320275749bb948c41e8eb5140da
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
por: Suneet Mittal, et al.
Publicado: (2021)

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Lucas C Godoy, et al.
Publicado: (2019)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019)

Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
por: Allegra Battistoni, et al.
Publicado: (2020)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method
por: Ali Çoner
Publicado: (2021)

New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method
por: Mustafa Arıcı, et al.
Publicado: (2021)

Strategies to Reduce Radiation Exposure in Electrophysiology and Interventional Cardiology
por: Sandeep Shankar, et al.
Publicado: (2020)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Human Immunodeficiency Virus disease and cardiac surgery – where are we?
por: David Blyth
Publicado: (2017)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
por: Charles Simonton, et al.
Publicado: (2020)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
por: Per Eriksson, et al.
Publicado: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
por: Marina Cecelja, et al.
Publicado: (2021)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Heart Rate Variability and Cardiovascular Fitness: What We Know so Far
por: Souza HCD, et al.
Publicado: (2021)

Hybrid Convergent Procedure for the Treatment of Persistent and Long-standing Persistent Atrial Fibrillation
por: David B DeLurgio, et al.
Publicado: (2021)

Anticoagulation in Peripheral Artery Disease: Are We There Yet?
por: Alessandro Cannavale, et al.
Publicado: (2020)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021)

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
por: Ajay K. Gupta
Publicado: (2018)

Perioperative myocardial damage and the incidence of type 2 myocardial infarction in patients with intermediate and high cardiovascular risk
por: Miraç Vural Keskinler, et al.
Publicado: (2021)

Comparison of anthropometric indices as predictors of the risk factors for cardiovascular disease in Iran: The PERSIAN Guilan Cohort Study
por: Marjan Mahdavi-Roshan, et al.
Publicado: (2021)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Johan Ärnlöv, et al.
Publicado: (2021)

Reduced exercise capacity in the adult with repaired tetralogy of Fallot: More evidence. Now what to do?
por: Rose Tompkins, et al.
Publicado: (2021)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Gheorghe-Andrei Dan
Publicado: (2019)

Diabetes and mortality in patients with COVID-19: Are we missing the link?
por: Marco Toselli2, et al.
Publicado: (2021)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Shahnam Sharif, et al.
Publicado: (2021)

Traditional cardiovascular risk factors are associated with adverse cardiac events in pregnant women with elevated right ventricular systolic pressure
por: William Marshall, et al.
Publicado: (2021)

Thrombosis in COVID-19: We still need to learn a lot
por: Cem Barçın
Publicado: (2021)

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Zuoan Qin, et al.
Publicado: (2021)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)